Status:
COMPLETED
Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Stanley Medical Research Institute
Conditions:
Cognition in Schizophrenia
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
This research is being done because people with schizophrenia often have problems with thinking including learning, remembering, paying attention, and problem solving. During this study, we will test ...
Detailed Description
Persons with schizophrenia in a stable and residual antipsychotic- treated clinical condition for at least 8 weeks will be recruited from several public mental health treatment settings into the UTSW ...
Eligibility Criteria
Inclusion
- DSM-IV diagnosis of schizophrenia or schizoaffective disorder.
- Males and females.
- Ages 18-60 years old.
- All races and ethnicities.
Exclusion
- Diagnosis of an organic brain disease.
- Diagnosis of DSM-IV alcohol or substance abuse within the last month or DSM-IV alcohol or substance dependence within the last 3 months.
- Meet criteria for primary negative symptoms, established by clinical judgment.
- Current or past history of clozapine treatment for antipsychotic non-response.
- Patients hospitalized in a psychiatric hospital within the previous 30 days.
- Patients with an unstable medical condition, as determined by the Investigator
- Colorblindness
- Concurrent treatment with electroconvulsive therapy or psychotherapy.
- Pregnant women.
- Must be able to read, speak, and understand English.
- We do not have the resources necessary to properly study non-English speaking patients in this study. The computer software used for cognitive remediation and some clinical assessments are only available in English. The need to provide such resources in foreign languages would be prohibitive to the successful completion of the study.
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT00628394
Start Date
September 1 2003
End Date
February 1 2011
Last Update
September 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390